Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Tables 1-5 from Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial
  1. Home
  2. Publications
  3. Supplementary Tables 1-5 from Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial

Supplementary Tables 1-5 from Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial

Authors:
  • TWTerence M. Williams
    Terence M. Williams
  • ASAndreas Schneeweiss
    Andreas Schneeweiss
  • Christian Jackisch
    Christian Jackisch
  • CSChangxian Shen
    Changxian Shen
  • KWKarsten E. Weber
    Karsten E. Weber
  • Peter A. Fasching
    Peter A. Fasching
  • CDCarsten Denkert
    Carsten Denkert
  • JFJenny Furlanetto
    Jenny Furlanetto
  • EHErnst Heinmöller
    Ernst Heinmöller
  • SSSabine Schmatloch
    Sabine Schmatloch
  • TKThomas Karn
    Thomas Karn
  • CSChristopher W. Szeto
    Christopher W. Szeto

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30708939
Abstract
No abstract available
Keywords
  • BIOMARKERS
  • PROGNOSTIC BIOMARKERS
  • BREAST CANCER
  • CHEMOTHERAPY
  • ADJUVANT CHEMOTHERAPY
  • CLINICAL TRIAL RESULTS
  • PHASE III CLINICAL TRIALS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.